| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/17/2003 | EP1343493A2 Use of(-) (3-halomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
| 09/17/2003 | EP1343492A2 Treatment of mucositis |
| 09/17/2003 | EP1343491A2 Use of pericyte apoptosis inhibitors for treating and/or preventing diabetic retinopathy |
| 09/17/2003 | EP1343486A1 Pharmaceutical or cosmetic composition and use of a pkc inhibitor with an mmp inhibitor for inhibiting langerhans' cell migration |
| 09/17/2003 | EP1343479A2 Aerogel powder therapeutic agents |
| 09/17/2003 | EP1343476A2 Preparation of large liposomes by infusion into peg |
| 09/17/2003 | EP1343475A2 Self forming, thermodynamically stable liposomes and their applications |
| 09/17/2003 | EP1343465A2 Use of dna repair enzymes as mmp-1 inhibitors |
| 09/17/2003 | EP1230260B1 Hcv ns3 protease inhibitors |
| 09/17/2003 | EP1187627B1 Uses of h-trek-1 polypeptides and polynucleotides encoding them |
| 09/17/2003 | EP1169056B1 Caspase-8 inhibitors for immunosuppression. |
| 09/17/2003 | EP1159295B1 Method of purifying whey of lactic acid fermentation by electrodialysis |
| 09/17/2003 | EP1140135B1 Cyclosporin solution |
| 09/17/2003 | EP1082131B1 Immunoregulator |
| 09/17/2003 | EP1033973B1 Encapsulation method |
| 09/17/2003 | EP1001798B1 Method for preventing or treating a human immunodeficiency virus infection |
| 09/17/2003 | EP0972782B1 Monoclonal antibody which recognizes the oligosaccharide n-glycolylated-galactose-glucose sialic acid in malignant tumors, and composition containing it |
| 09/17/2003 | EP0914114B1 Methods of treating type i hypersensitivity using monophosphoryl lipid a |
| 09/17/2003 | EP0831937B1 Immunological combination compositions and methods |
| 09/17/2003 | EP0796105B1 Use of the heterodimers S2/S4 and/or S3/S4 of the B-oligomer of pertussis toxin in the treatment of autoimmune diseases. |
| 09/17/2003 | EP0792165B1 Immunogenic compositions |
| 09/17/2003 | EP0697888B1 Conserved motif of hepatitis c virus e2/ns1 region |
| 09/17/2003 | EP0669988B1 Angiogenesis inhibitory antibodies |
| 09/17/2003 | EP0657520B9 Antioxidant |
| 09/17/2003 | EP0571613B1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| 09/17/2003 | CN1443242A Modified construct downstream of initiation codon for recombinant protein over expression |
| 09/17/2003 | CN1443241A Isolated nucleic acid molecules which encode T cell inducible factors, or interleukin-21, proteins encoded, and uses thereof |
| 09/17/2003 | CN1443239A Compositions and methods for therapy and diagnosis of breast cancer |
| 09/17/2003 | CN1443198A Ghrelin拮抗剂 Ghrelin Antagonist |
| 09/17/2003 | CN1443197A Acid-modified arabinogalactan protein composition |
| 09/17/2003 | CN1443196A Protein complex serving as vehicle for orally administerable medicaments |
| 09/17/2003 | CN1443195A LHRH-antagonists, production and use thereof as medicament |
| 09/17/2003 | CN1443192A Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof |
| 09/17/2003 | CN1443077A CD40-binding APC-activating molecules |
| 09/17/2003 | CN1443064A Administration of thiol-based chemoprotectant compound |
| 09/17/2003 | CN1442202A Biological preparation for preventing and treating heart and brain blood vessel disease and its application |
| 09/17/2003 | CN1442201A Compound containing osteoclast formation inhibiting factor and polysaccharide |
| 09/17/2003 | CN1442200A Medicine for preventing and treating AIDS |
| 09/17/2003 | CN1121413C Polypeptide compounds containing D-2-alkyltryptophan capable of promoting the release of growth hormone |
| 09/17/2003 | CN1121384C Penicillaminamide derivative |
| 09/17/2003 | CN1121379C Synthesis and use of retinene derivative having negative hormone and/or antagonist activities |
| 09/17/2003 | CN1121238C Novel cyclosporine preparation forms for oral administration of simple composition and high bio availability and process for producing them |
| 09/17/2003 | CN1121224C Pharmaceutical composition comprising compound having anti Xa activity and platelet aggregation antagonist compound |
| 09/16/2003 | US6620967 Ketosis-treating agent |
| 09/16/2003 | US6620923 Use for treatment of uterine cancer |
| 09/16/2003 | US6620922 Isolated polynucleotide of given sequence; kit |
| 09/16/2003 | US6620916 Reacting with amino group of ligand, in presence of transglutaminase, to form an amide bond; lower binding affinity for asialoglycoprotein receptor; accumulates in liver; use as anti-tumor anti-inflammatory and viricide |
| 09/16/2003 | US6620915 Monoclonal antibodies specific for integrin α-d subunit |
| 09/16/2003 | US6620914 Transcription factor islet-brain 1 (IB1) |
| 09/16/2003 | US6620912 Novel human protein of given nucleotide sequence; vectors, host cells, antibodies, and recombinant methods; for diagnosis and treatment of disorders including those in the immune system |
| 09/16/2003 | US6620911 Dolastatin 10 derivatives, of given formula; administering to infected human; useful as fungicides |
| 09/16/2003 | US6620910 Of given amino acid sequence; receptor agonists; increased metabolic stability; longer duration of action; use in treatment of non-insulin-dependent type II diabetes, obesity, and type I diabetes |
| 09/16/2003 | US6620909 Adipocyte complement related protein homolog zacrp2 |
| 09/16/2003 | US6620847 Copolymer-1 improvements in compositions of copolymers |
| 09/16/2003 | US6620844 Treating obesity and non-insulin-dependent (type II) diabetes mellitus (NIDDM) by specifically targeting the genes and gene products of cathepsins |
| 09/16/2003 | US6620792 Monosialoganglioside GM1 or a derivative thereof, namely, the inner ester AGF2 and the methyl ester AGF4, suitable for the treatment of Parkinson's disease. A further object of the present invention is a therapy for Parkinson's Disease |
| 09/16/2003 | US6620790 Stimulate hair growth |
| 09/16/2003 | US6620789 Compounds are provided that inhibit the interaction of an IGF with any one of its binding proteins and not to a human IGF receptor. These IGF agonist compounds, which include peptides, are useful to increase serum and tissue levels of active IGFs |
| 09/16/2003 | US6620788 Enteral sorbefacients |
| 09/16/2003 | US6620785 Treatment of Mycobacterial diseases by administration of bactericidal/permeability-increasing protein products |
| 09/16/2003 | US6620784 Uses of VEGF-E |
| 09/16/2003 | US6620783 Human SMN-like protein (HSLP) and polynucleotides which identify and encode HSLP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating |
| 09/16/2003 | US6620782 compounds having Formula I are potent inhibitors of caspases and apoptotic cell death. Therefore, the inhibitors of this invention can retard or block cell death in a variety of clinical conditions in which the loss of cells, tissues or |
| 09/16/2003 | US6620781 Glycopeptide carboxy-saccharide derivatives |
| 09/16/2003 | US6620779 Administering to an individual for tumor treatment a chemotherapeutically effective amount of antitumor agent carboplatin, and erythropoietin a hematocrit elevator which is administered befor or concurrently with antitumor agent |
| 09/16/2003 | US6620778 Cysteine/glycine rich peptides |
| 09/16/2003 | US6620615 G-protein coupled receptor—encoding nucleic acids |
| 09/16/2003 | US6620608 Peptides for use in the treatment of cholesterol defects |
| 09/16/2003 | US6620606 New human cathepsin (LCAP) and polynucleotides which identify and encode LCAP. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders |
| 09/16/2003 | US6620603 Human mitogenic oxidase |
| 09/16/2003 | US6620422 Compositions containing a peptide and polylactic-glycolic acid suitable for preparing subcutaneous implants with an extended release period |
| 09/16/2003 | US6620419 Cosmetic or dermopharmaceutical use of peptides for healing, hydrating and improving skin appearance during natural or induced ageing (heliodermia, pollution) |
| 09/16/2003 | US6620415 Parkinson's disease treatment |
| 09/16/2003 | US6620413 Obesity protein derivative covalently bonded to a nonproteinaceous polymer, wherein said derivative is capable of reducing body weight and/or food intake in an individual |
| 09/16/2003 | US6620411 Method for inhibiting brain tumor or colon carcinoma |
| 09/16/2003 | US6620406 Methods for treatment of periodontal diseases and lesions using bone morphogenetic proteins |
| 09/16/2003 | US6620382 Method and compositions for treatment of cancers |
| 09/16/2003 | US6620325 Purification process for cyclosporin |
| 09/16/2003 | CA2294090C Method and product using sturgeon notochord for alleviating the symptoms of arthritis |
| 09/16/2003 | CA2250274C Method and apparatus for preparing an acellular red blood cell substitute |
| 09/16/2003 | CA2215695C .beta.-sheet mimetics and use thereof as protease inhibitors |
| 09/16/2003 | CA2182183C Treatment of ovarian estrogen dependent conditions |
| 09/16/2003 | CA2172493C Use of angiotensin iii and analogs thereof in tissue repair |
| 09/16/2003 | CA2145985C Vascular endothelial cell growth factor antagonists |
| 09/16/2003 | CA2131719C Nucleic acid sequences coding for or complementary to nucleic acid sequences coding for interleukin 9 receptor |
| 09/16/2003 | CA2130577C Combinations of ace inhibitors and diuretics |
| 09/16/2003 | CA2119463C Glial cell line-derived neutrophic factor |
| 09/16/2003 | CA2108288C Liposomal cyclosporin formulation and process for the preparation thereof |
| 09/16/2003 | CA2107219C S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof |
| 09/16/2003 | CA2090860C Synthesis of equimolar multiple oligomer mixtures, especially of oligopeptide mixtures |
| 09/16/2003 | CA2081343C Therapeutic agents for the treatment of multidrug resistance to cancers |
| 09/16/2003 | CA2078759C Novel carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace |
| 09/16/2003 | CA2054590C Novel cyclosporins |
| 09/15/2003 | CA2421490A1 Medicament against thrombotic diseases |
| 09/13/2003 | CA2421488A1 Method for reconstituting lyophilized proteins |
| 09/12/2003 | WO2003074992A2 Phosphorylated proteins and uses related thereto |
| 09/12/2003 | WO2003074736A1 Diagnostics and remedies for malignant brain tumor |
| 09/12/2003 | WO2003074712A1 Dna vaccines encoding cea and a cd40 ligand and methods of use thereof |
| 09/12/2003 | WO2003074702A1 Novel protein and dna thereof |
| 09/12/2003 | WO2003074694A1 Adipocyte differentiation-associated genes and proteins |